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Abstract
Background: Pseudomonas aeruginosa is an important cause of hospital-acquired infections that can create serious problem for
patients and physicians. Many factors are associated with the antibiotic resistance of P. aeruginosa, such as eﬄux pumps.
Objectives: The aim of this study was the phenotypic and molecular detection of eﬄux pumps in our clinical P. aeruginosa isolates
in a comparison between burn and non-burn specimens.
Materials and Methods: In this study, clinical strains of P. aeruginosa were collected from burn and non-burn specimens from April
- July 2013. Antibiotic susceptibility testing of the isolates was performed after biochemical and molecular identification. The min-
imum inhibitory concentration (MIC) of imipenem, cefepime, gentamycin, and ciprofloxacin, with and without carbonyl cyanide
3-chlorophenylhydrazone (CCCP), was determined for phenotypic detection of eﬄux pumps.
Results: Our results confirmed 203 and 60 P. aeruginosa isolates from burn and non-burn specimens, respectively. The most antibi-
otic resistance was observed against tobramycin in both group of specimens, and no resistance was seen to colistin. Phenotypic
detection of eﬄux pumps was determined to correlate to a > 4-fold decrease in the MICs of the tested antibiotics with CCCP com-
pared to without CCCP in 57 strains.
Conclusions: High-level antibiotic resistance can occur as a result of multidrug eﬄux pumps combined with other mechanisms of
resistance. However, the association between over-expression of these genes and highly resistant clinical isolates cannot be ignored.
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1. Background
Pseudomonas aeruginosa is a major cause of nosoco-
mial infections, especially in burn patients (1-4). One of
the important characteristics of P. aeruginosa is high an-
timicrobial resistance to antimicrobial agents used in clin-
ical settings (5). Some of this high antimicrobial resis-
tance is related to OprD protein in P. aeruginosa, with
less permeability, the potential to produce several types
of carbapenemase enzymes, and variable eﬄux pumps
(6-8). Eﬄux pumps are antibiotic-resistance mechanisms
that are related to the inability of antibiotics to perme-
ate bacterial cells, keeping them out of the cell and de-
creasing antibiotic concentrations inside the cell (8). The
resistant-nodulation-division (RND) family eﬄux pump is
an intrinsic antibiotic resistance mechanism that can cre-
ate antibiotic cross-resistance in P. aeruginosa, particu-
larly in clinical isolates recovered from burn patients (8-
10). Four of these eﬄux pumps are more prevalent in P.
aeruginosa: MexXY-OprM can cause resistance to amino-
glycosides, beta-lactams, and fluoroquinolones; MexEF-
OprN is related to resistance to fluoroquinolones; and
MexCD-OprJ and MexAB-OprM can cause resistance to beta-
lactams and fluoroquinolones (9-11). Therefore, detec-
tion of MexXY-OprM in aminoglycoside-, beta-lactam-, and
fluoroquinolone-resistant bacteria can be helpful for iden-
tification of the mechanism of antibiotic resistance in
these bacteria, as this eﬄux pump group can create resis-
tance to these three antibiotic families (9). Eﬄux pump
inhibitors are widely used to detect various active eﬄux
pumps (12). Carbonyl cyanide 3-chlorophenylhydrazone
(CCCP) (an uncoupler of oxidative phosphorylation, which
disrupts the proton gradient of the membranes) is a con-
ventional eﬄux pump inhibitor that can increase the sus-
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ceptibility of a number of multi-drug resistant (MDR) bac-
teria (12).
2. Objectives
The aim of this study was the phenotypic detection of
eﬄux pumps in antibiotic-resistant P. aeruginosa by using
CCCP as an eﬄux pump inhibitor in clinical P. aeruginosa
isolates in a comparison between burn and non-burn sam-
ples.
3. Materials and Methods
3.1. Bacterial Isolates
Bacterial isolates were collected from burn-wound in-
fections at Motahari hospital (n = 203) and from different
clinical specimens, such as urine and blood cultures, at Mi-
lad hospital (n = 60) from April to July 2013. Identification
of the isolates was performed by phenotypic testing and
PCR as a molecular method at the pediatric infectious re-
search center of the Mofid hospital laboratory. PCR am-
plification of I lipoprotein (oprI) was performed for detec-
tion of genus, and of L lipoprotein (oprL) was performed
for detection of species of this organism. The sequences of
primers and PCR conditions were described previously (5).
Direct sequencing of PCR-amplified products was carried
out using an ABI 3730X capillary sequencer (Genfanavaran,
Macrogen, Seoul, Korea).
3.2. Antibiotic Susceptibility Testing
The antibiotic susceptibility testing was performed by
the disc diffusion method on Mueller-Hinton agar (MHA)
using ceftazidime (30µg), cefepime (30µg ), imipenem (10
µg), ticarcillin (75µg), ticarcillin-clavulanic acid (75/10µg),
piperacillin (100 µg), piperacillin-tazobactam (100/10 µg),
ciprofloxacin (5 µg), gentamicin (10 µg), tobramycin (10
µg), amikacin (30 µg), tetracycline (30 µg), trimethoprim
(5µg), trimethoprim-sulfamethoxazole (1.25/23.75µg), and
colistin (10 µg). According to the clinical and laboratory
standards institute (CLSI) 2013 (13). The antibiotic disks
used in this study were purchased from Mast Diagnos-
tics (UK). P. aeruginosa ATCC 27853 was used as the con-
trol strain for the antibiotic susceptibility testing. Resis-
tance to at least three families of tested antibiotics indi-
cated MDR.
3.3. Treatment With Eﬄux Pump Inhibitor
For detection of the eﬄux pump mechanism, eﬄux
pump inhibitor CCCP was added to each of the MHA plates,
containing 0.5 - 1024 µg/mL gentamicin, 0.5 - 1024 µg/mL
cefepime, 0.5 - 256 µg/mL imipenem, and 0.5 - 128 µg/mL
ciprofloxacin, as representatives of three important an-
tibiotic families. The final concentration of CCCP (C2759
Sigma-Aldrich, France) in the MHA with and without an-
tibiotics was 25 µg/mL (12, 14) simultaneously for each an-
tibiotic. The positive criterion for the presence of active ef-
flux pumps in the isolates was the MIC of the tested antibi-
otics decreasing at least 4-fold when CCCP was added (12,
14). The control strains included PAO1 (wild type).
3.4. Statistical Analysis
The involvement of active eﬄux pumps in the burn
and non-burn specimens was analyzed using SPSS soft-
ware, version 18.0 The Chi-square of all antibiotics was de-
termined between the burn and non-burn specimen iso-
lates, and a P < 0.05 was considered significant.
4. Results
In this cross-sectional study, 203 P. aeruginosa isolates
were confirmed from burn-wound infections and 60 were
collected from different clinical specimens at Milad hos-
pital. The isolates were detected by phenotypic and PCR
methods (Figure 1). The age of the patients was between 2
and 73 years.
Figure 1. Phenotypic and PCR Methods
A) PCR amplification of oprI gene among suspected isolates for detection of Pseu-
domonas spp. M, 1 kb DNA size marker; lane 1, positive control P. aeruginosa ATCC
27853; lanes 2 and 3, positive isolates. B) PCR amplification of oprL gene among sus-
pected isolates for detection of P. aeruginosa. M, 1 kb DNA size marker; lane 1, positive
control P. aeruginosa ATCC 27853; lanes 2 and 3, positive isolates.
According to the results of antibiotic susceptibility
testing, the most resistance was observed against to-
bramycin, and none of the strains showed resistance to col-
istin in either the burn or the non-burn isolates. The antibi-
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otic susceptibility test results for the burn and non-burn
specimens are shown in Figure 2.
Figure 2. Results of Antibiotic Susceptibility Testing by Disc Diffusion Method
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CTX, cefotaxime; CAZ, ceftazidime; CEF, cefepime; IMI, imipenem; PTZ, piperacillin-
tazobactam; PRL, piperacillin; TC, ticarcillin; TC-c, ticarcillin-clavulanic acid; GM,
gentamicin; AK, amikacin; TO, tobramycin; TM, trimethoprim; SXT, trimethoprim-
sulfamethoxazole; CI, ciprofloxacin; T, tetracycline; CO, colistin. Series 1, burn iso-
lates; Series 2, non-burn isolates.
The MIC range for the P. aeruginosa isolates is shown
in Table 1, based on the sources of the bacterial isolates
and on the tested antibiotics. Seventy-eight percent, 82%,
80% and 78% of the burn isolates showed MICs in the re-
sistance range for imipenem, ciprofloxacin, gentamicin,
and cefepime, respectively. On the other hand, 35%, 38%,
53%, and 47% of the non-burn isolates showed MICs in the
resistance range for imipenem, ciprofloxacin, gentamicin
and cefepime, respectively. Overall, resistance to the tested
antibiotics was significantly lower in specimens isolated
from non-burn patients than in those from burn patients
(P≤ 0.05).
4.1. Effects of Eﬄux Pump Inhibitors on Antibiotic Resistance
The decreased MICs of antibiotics with CCCP in com-
parison to antibiotics alone are shown in Table 2, based
on burn and non-burn specimens. A 4-fold or greater de-
crease in the MIC of the antibiotic with CCCP against the an-
tibiotic alone was the criterion for significance (12-14). De-
creased MICs of tested antibiotics in the presence of CCCP
was significantly more common in the burn isolates than
in the non-burn isolates (P≤0.05). Therefore, the burn iso-
lates became significantly less resistant with eﬄux pump
inhibitors (P≤ 0.05).
All bacteria grew well on the MHA plates with CCCP that
did not contain antibiotics, indicating that 25 µg/mL of
CCCP did not have an antibacterial effect by itself.
5. Discussion
P. aeruginosa can cause healthcare-associated infec-
tions. In recent years, increased rates of MDR and/or
extensively-drug resistant (XDR) isolates of this Gram-
negative bacterium have become a challenging issue
worldwide (15, 16). The resistance rate to most antibiotics,
such as beta-lactams, gentamycin, and fluoroquinolones,
which are used clinically to treat P. aeruginosa infections,
are increasing throughout the world, including Iran (1, 4,
5). In a survey conducted in Mexico, more than 50% of P.
aeruginosa isolates were MDR, with resistance to 12 tested
antibiotics, including beta-lactams, aminoglycosides, and
ciprofloxacin (17). Additionally, recent studies in Iran have
found increased MDR and/or XDR of P. aeruginosa in burn
infections (5). Similar to these previous studies, all of our
strains isolated from burn wounds showed greater than
70% and 79% resistance to broad-spectrum cephalosporins
and aminoglycosides, respectively (compared to 47% and
43% in non-burn specimens). However, the resistance
rate observed to imipenem in the isolates included in the
present investigation was higher than in studies from In-
dia and Tunisia (18.9% and 35%, respectively) (18, 19). This
discrepancy could be related to differences in the quality
programs of antimicrobial therapies, patterns of antibi-
otic resistance, geographic conditions, and environmental
factors in various countries. According to the results of re-
cent studies and the present one, the emergence of highly
resistant P. aeruginosa strains to tested antibiotics among
hospitalized burned patients in Tehran should be consid-
ered. In the current study, the MICs of the tested antibiotics
in burn specimens were significantly higher than in non-
burn specimens (P≤ 0.05). This can be related to the use
of broad-spectrum antibiotics in burn patients more often
than in non-burn patients, and the selection of antibiotic-
resistant bacteria in burn patients. Some recent studies
have indicated that antibiotic eﬄux pumps can be an im-
portant mechanism of resistance, sometimes including
cross-resistance, in a number of clinically important bacte-
ria, including P. aeruginosa (12, 14). Generally, high-level re-
sistance occurs as a result of multidrug eﬄux pumps with
another mechanism of antibiotic resistance, but an asso-
ciation with over-expression of these genes among highly
resistant clinical isolates cannot be ignored.
Eﬄux pump inhibitors have been shown to reverse
MDR in P. aeruginosa and other bacteria (8, 10). The ef-
fects of these compounds, such as CCCP, on MIC were ex-
amined in the same studies (12, 14). Rajamohan et al. (20)
found that the addition of CCCP at a final concentration
of 25 µg/mL greatly reduced the MIC of various biocides,
from 2- to 12-fold. These results suggest that antibiotic ef-
flux pumps are involved in the resistance to many antibi-
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Table 1. MIC Range of P. aeruginosa
Value Antibiotic MIC, (%)
Imipenem Ciprofloxacin Gentamicin Cefepime
S I R S I R S I R S I R
Burn specimens 6 16 78 13 5 82 12 8 80 18 4 78
Non-burn specimens 55 10 35 43 19 38 43 4 53 51 2 47
Table 2. Decrease of MICs of Antibiotics With CCCP, in % (at Least 4-Fold)
MIC Increase Cefepime Imipenem Ciprofloxacin Gentamicin
Burn Non-Burn Burn Non-Burn Burn Non-Burn Burn Non-Burn
4-fold 13 9 5 4 8 5 9 6
8-fold 7 4 5 3 5 3 1 1
16-fold 1 1 6 4 5 3 3 2
32-fold 3 - 2 1 8 5 3 2
64-fold - - 3 1 1 1 2 1
128-fold 3 1 - - - - 3 1
256-fold - - - - - - 2 -
1,024-fold - - - - - - 1 -
otics that are used for the treatment of clinical P. aerugi-
nosa isolates. The results of CCCP testing in our study in-
dicated that eﬄux pumps are present in burn specimens
significantly more often than in non-burns (P ≤ 0.05).
Choudhury et al. (3) conducted a study to detect active ef-
flux pumps in ciprofloxacin-resistant P. aeruginosa isolates
from different clinical specimens, and found that 23% of
isolates showed a positive reaction with CCCP and were
considered to be strains with active eﬄux pumps. In the
current study, this rate was 17% for the non-burn speci-
mens and 27% for the burn samples. Ardebili et al. (12)
detected active eﬄux pumps in Acinetobacter baumannii in
burn isolates by CCCP; according to their results, 86% of
these strains become less resistant to ciprofloxacin in the
presence of CCCP as an eﬄux pump inhibitor. This is a
higher rate than found in the current study (27%), which
can be related to the differentiation between types of bac-
teria. These results may indicate the greater frequency of
active eﬄux pumps in antibiotic-resistant A. baumannii in
comparison with P. aeruginosa.
In conclusion, the Mex family of eﬄux pumps are de-
scribed in P. aeruginosa, with over-expression conferring
resistance to clinically used antibiotics and other antimi-
crobial agents.
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